Italy’s Chiesi is acquiring Amryt Pharma for its breakthrough therapy targeting epidermolysis bullosa, also known as ‘butterfly skin’.
Read more: Irish pharma company Amryt snapped up for up to $1.5bn
Italy’s Chiesi is acquiring Amryt Pharma for its breakthrough therapy targeting epidermolysis bullosa, also known as ‘butterfly skin’.
Read more: Irish pharma company Amryt snapped up for up to $1.5bn
